[go: up one dir, main page]

NO961385L - Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin - Google Patents

Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin

Info

Publication number
NO961385L
NO961385L NO961385A NO961385A NO961385L NO 961385 L NO961385 L NO 961385L NO 961385 A NO961385 A NO 961385A NO 961385 A NO961385 A NO 961385A NO 961385 L NO961385 L NO 961385L
Authority
NO
Norway
Prior art keywords
carnitine
butyrobetaine
crotonobetaine
gamma
metabolism
Prior art date
Application number
NO961385A
Other languages
English (en)
Other versions
NO961385D0 (no
NO319058B1 (no
Inventor
Thomas Zimmermann
Josef Werlen
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of NO961385D0 publication Critical patent/NO961385D0/no
Publication of NO961385L publication Critical patent/NO961385L/no
Publication of NO319058B1 publication Critical patent/NO319058B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/007Carnitine; Butyrobetaine; Crotonobetaine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/743Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Agrobacterium; Rhizobium; Bradyrhizobium

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19961385A 1993-10-08 1996-04-03 Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin. NO319058B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH303693 1993-10-08
CH3694 1994-01-06
PCT/EP1994/003317 WO1995010613A1 (de) 1993-10-08 1994-10-07 Gene für den butyrobetain/crotonobetain-l-carnitin-stoffwechsel und ihre verwendung zur mikrobiologischen herstellung von l-carnitin

Publications (3)

Publication Number Publication Date
NO961385D0 NO961385D0 (no) 1996-04-03
NO961385L true NO961385L (no) 1996-06-03
NO319058B1 NO319058B1 (no) 2005-06-13

Family

ID=25683317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961385A NO319058B1 (no) 1993-10-08 1996-04-03 Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin.

Country Status (17)

Country Link
US (1) US5759824A (no)
EP (1) EP0722500B1 (no)
JP (1) JP3708543B2 (no)
KR (1) KR100346293B1 (no)
CN (2) CN1058523C (no)
AT (1) ATE257515T1 (no)
AU (1) AU7854694A (no)
CA (1) CA2173115C (no)
CZ (1) CZ288247B6 (no)
DE (1) DE59410350D1 (no)
FI (1) FI118568B (no)
HU (1) HU220798B1 (no)
NO (1) NO319058B1 (no)
PL (1) PL180300B1 (no)
RU (1) RU2133773C1 (no)
SK (1) SK280580B6 (no)
WO (1) WO1995010613A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19850426A1 (de) * 1998-10-27 2000-05-04 Sigma Tau Ind Farmaceuti gamma-Butyrobetainyl-Coenzym A und Verfahren zu seiner Herstellung
EP1452604A3 (en) * 1998-10-27 2005-03-30 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Coenzyme useful for the synthesis of L-Carnitine
US6337197B2 (en) 1998-10-27 2002-01-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Coenzymes useful for the synthesis of L-carnitine
DE19850433A1 (de) * 1998-10-27 2000-05-25 Sigma Tau Ind Farmaceuti Crotonobetainyl-Coenzym A, Verfahren zu seiner Herstellung
US6720168B2 (en) 2000-08-04 2004-04-13 Genencor International, Inc. 2,5-DKG permeases
DE60117566T2 (de) * 2000-08-04 2007-01-11 Genencor International, Inc., Palo Alto Erhöhte herstellung von 2-keto-l-gulonsäure
WO2002061094A2 (de) * 2001-01-31 2002-08-08 Lonza Ag Mikrobiologisches verfahren zur herstellung von l-carnitin
US7229811B2 (en) 2001-08-03 2007-06-12 Genencor International, Inc. 2,5-diketo-D-gluconic acid (2,5-DKG) permeases
US7335496B2 (en) 2003-06-05 2008-02-26 Ajinomoto Co., Inc. Method for producing target substance
KR101166026B1 (ko) 2004-07-12 2012-07-19 씨제이제일제당 (주) 뉴로스포라 크라사 유래 l-카르니틴 생합성 관련유전자를 포함하는 엔테로박테리아세 속 미생물 및 이를이용한 l-카르니틴의 제조방법
CN101212956A (zh) 2005-07-05 2008-07-02 隆萨股份公司 生产干肉碱粉末或颗粒的喷雾干燥法
EP1904632B1 (en) 2005-07-19 2010-06-30 CJ CheilJedang Corporation A microorganism of enterobacteriacae genus haboring genes associated with l-carintine biosynthesis and methos of producing l-carnitine using the microorganism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59192095A (ja) * 1983-04-13 1984-10-31 Ajinomoto Co Inc L−カルニチンの製造法
IE902689A1 (en) * 1989-07-28 1991-02-27 Lonza Ag A method of discontinuous production of l-carnitine by a¹microbiological process
IT1240833B (it) * 1990-05-14 1993-12-17 Sigma Tau Ind Farmaceuti Procedimento biocatalitico per la produzione di l-(-)- carnitina da crotonilbetaina e ceppi di proteeae per l'uso in tale procedimento
RU2099418C1 (ru) * 1991-11-21 1997-12-20 Лонца Аг Фрагмент днк, обеспечивающий использование бетаина, рекомбинантная плазмидная днк с фрагментом днк, обеспечивающим использование бетаина, штамм бактерий rhizobium/agrobacterium, предназначенный для стабильного хранения плазмиды с фрагментом днк, способ получения штамма бактерий

Also Published As

Publication number Publication date
PL180300B1 (pl) 2001-01-31
KR100346293B1 (ko) 2002-11-30
JP3708543B2 (ja) 2005-10-19
SK43196A3 (en) 1996-10-02
CN1058523C (zh) 2000-11-15
NO961385D0 (no) 1996-04-03
CA2173115C (en) 2005-07-26
US5759824A (en) 1998-06-02
NO319058B1 (no) 2005-06-13
AU7854694A (en) 1995-05-04
EP0722500B1 (de) 2004-01-07
DE59410350D1 (de) 2004-02-12
JPH09503390A (ja) 1997-04-08
CZ100596A3 (en) 1996-10-16
HUT74825A (en) 1997-02-28
FI961537L (fi) 1996-04-04
WO1995010613A1 (de) 1995-04-20
CA2173115A1 (en) 1995-04-20
CN1282791A (zh) 2001-02-07
CN1157480C (zh) 2004-07-14
EP0722500A1 (de) 1996-07-24
PL313968A1 (en) 1996-08-05
ATE257515T1 (de) 2004-01-15
CZ288247B6 (en) 2001-05-16
RU2133773C1 (ru) 1999-07-27
FI118568B (fi) 2007-12-31
CN1133066A (zh) 1996-10-09
SK280580B6 (sk) 2000-04-10
HU220798B1 (hu) 2002-05-28
FI961537A0 (fi) 1996-04-04

Similar Documents

Publication Publication Date Title
Mercenier et al. Catabolism of L-arginine by Pseudomonas aeruginosa
NO961385L (no) Gener for butyrobetain/krotonobetain-L-carnitinstoffskiftet og deres anvendelse for mikrobiologisk fremstilling av L-carnitin
WO2003004675A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
WO2003008609A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pykf gene
PL326915A1 (en) Microorganisms and fermentation processes used in production of l-cysteine, l-cystine, n-acetylserine or thiazolydine derivatives
WO2003008616A3 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACIDS USING STRAINS OF THE ENTEROBACTERIACEAE FAMILY WHICH CONTAIN AN ATTENUATED aceK GENE
EP1095158A4 (en) METHOD AND MATERIALS FOR THE PRODUCTION OF GLUCOSAMINE
PL1608764T3 (pl) Sposób wytwarzania L-aminokwasów przy zastosowaniu szczepów rodziny Enterobacteriaceae z nadekspresją genu GALP, kodującego symporter galaktoza proton
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
HU0000747D0 (en) Process for the fermentative production of l-amino acids using coryneform bacteria
Minami et al. A mutant Bacillus subtilis γ-glutamyltranspeptidase specialized in hydrolysis activity
RU96108818A (ru) Гены бутиробетаин-/кротонобетаин- l-карнитин-метаболизма и их применение для микробиологического получения l-карнитина
WO2003023044A3 (en) Process for the production of l-amino acids using coryneform bacteria
GB2330144A (en) Process for preparing doxorubicin
HUP0002022A2 (hu) Eljárás L-aminosavak fermentációs előállítására és az accDA-gént kódoló nukleotidszekvenciák
NO20020665L (no) Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner
AU2002346803A1 (en) Genes encoding for carbon metabolism and energy-producing proteins
AP9901463A0 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
AU4302000A (en) Genome sequence and polypeptides of pyrococcus (abissy), fragment and uses thereof
Sekhar et al. Functional parametric influence on glutaminase free l-asparaginase production by Amycolatopsis thermoflava SFMA-103
MARUO et al. STEPWISE ENHANCEMENT OF PRODUCTIVITY OF THERMOSTABLE AMYLASE IN BACILLUS LICHENIFORMIS BY A SERIES OF MUTATIONS1
AU5049100A (en) Phage-dependent super-production of biologically active protein and peptides
AU2002342763A1 (en) Process for the preparation of non-aromatic l-amino acids using strains of the enterobacteriaceae family
GB9724627D0 (en) Gram positive microorganism formate pathway
CO5290295A1 (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees